drugset
drugset / Trial / NCT03583905

Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 Tablet

NCT03583905 ↗

Phase 3 Completed 154 enrolled Chong Kun Dang Pharmaceutical
RandomizedParallel-groupDouble-blindTreatment

Summary

To Evaluate the Efficacy and Safety of CKD-333

Timeline

Start
2018-04-04
Primary completion
2019-07-17
Completion
2019-07-17

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-330 Unknown — —
Subject D086 Unknown — —
Comparator D723 Unknown — —

Indications

No indication recorded.